Taiwan FDA registration 7039dec32bf25a518304001ddb74efa5
“Bard” Magnum Disposable Core Tissue Biopsy Needle
TW: “巴德”瑪格寧可拋棄式核心組織取樣針
Taiwan·Risk Class 2·MD·BARD PERIPHERAL VASCULAR, INC.·Registered Sep 14, 2016 – Sep 14, 2026ActiveRegistration details
- Analysis ID
- 7039dec32bf25a518304001ddb74efa5
- License Form
- Ministry of Health Medical Device Import No. 028835
- Customs Code
- DHA05602883504
Company information
- Manufacturer
- BARD PERIPHERAL VASCULAR, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology-urology devices
- Product Type (Level 2)
- H1075 Gastroenterology - Urology biopsy instruments
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 14, 2016
- Expiry Date
- Sep 14, 2026
About this record
Access comprehensive regulatory information for “Bard” Magnum Disposable Core Tissue Biopsy Needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7039dec32bf25a518304001ddb74efa5 and manufactured by BARD PERIPHERAL VASCULAR, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices